Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29276 - 29300 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	SULF1	23213	upregulated	Dasatinib results in increased expression of SULF1 mRNA	8q13.2-q13.3	A21899
Dasatinib	Approved Investigational	SULF2	55959	upregulated	Dasatinib results in increased expression of SULF2 mRNA	20q13.12	A21899
Dasatinib	Approved Investigational	SVEP1	79987	upregulated	Dasatinib results in increased expression of SVEP1 mRNA	9q31.3	A21899
Dasatinib	Approved Investigational	SYNPO2	171024	upregulated	Dasatinib results in increased expression of SYNPO2 mRNA	4q26	A21899
Dasatinib	Approved Investigational	SYT15	83849	upregulated	Dasatinib results in increased expression of SYT15 mRNA	10q11.22	A21899
Dasatinib	Approved Investigational	TACC3	10460	downregulated	Dasatinib results in decreased expression of TACC3 mRNA	4p16.3	A21899
Dasatinib	Approved Investigational	TCF19	6941	downregulated	Dasatinib results in decreased expression of TCF19 mRNA	6p21.33	A21899
Dasatinib	Approved Investigational	TCP11L2	255394	upregulated	Dasatinib results in increased expression of TCP11L2 mRNA	12q23.3	A21899
Dasatinib	Approved Investigational	TDP1	55775	downregulated	Dasatinib results in decreased expression of TDP1 mRNA	14q32.11	A21899
Dasatinib	Approved Investigational	TEX30	93081	downregulated	Dasatinib results in decreased expression of TEX30 mRNA	13q33.1	A21899
Dasatinib	Approved Investigational	TGFB2	7042	upregulated	Dasatinib results in increased expression of TGFB2 mRNA	1q41	A21899
Dasatinib	Approved Investigational	THBS2	7058	upregulated	Dasatinib results in increased expression of THBS2 mRNA	6q27	A21899
Dasatinib	Approved Investigational	THBS3	7059	upregulated	Dasatinib results in increased expression of THBS3 mRNA	1q22	A21899
Dasatinib	Approved Investigational	TICRR	90381	downregulated	Dasatinib results in decreased expression of TICRR mRNA	15q26.1	A21899
Dasatinib	Approved Investigational	TIMELESS	8914	downregulated	Dasatinib results in decreased expression of TIMELESS mRNA	12q13.3	A21899
Dasatinib	Approved Investigational	TIPIN	54962	downregulated	Dasatinib results in decreased expression of TIPIN mRNA	15q22.31	A21899
Dasatinib	Approved Investigational	TK1	7083	downregulated	Dasatinib results in decreased expression of TK1 mRNA	17q25.3	A21899
Dasatinib	Approved Investigational	TM6SF1	53346	upregulated	Dasatinib results in increased expression of TM6SF1 mRNA	15q25.2	A21899
Dasatinib	Approved Investigational	TMEM155	132332	upregulated	Dasatinib results in increased expression of TMEM155 mRNA	4q27	A21899
Dasatinib	Approved Investigational	TMPO	7112	downregulated	Dasatinib results in decreased expression of TMPO mRNA	12q23.1	A21899
Dasatinib	Approved Investigational	TNS3	64759	upregulated	Dasatinib results in increased expression of TNS3 mRNA	7p12.3	A21899
Dasatinib	Approved Investigational	TOP2A	7153	downregulated	Dasatinib results in decreased expression of TOP2A mRNA	17q21.2	A21899
Dasatinib	Approved Investigational	TP53INP1	94241	upregulated	Dasatinib results in increased expression of TP53INP1 mRNA	8q22.1	A21899
Dasatinib	Approved Investigational	TPD52L1	7164	upregulated	Dasatinib results in increased expression of TPD52L1 mRNA	6q22-q23	A21899
Dasatinib	Approved Investigational	TPX2	22974	downregulated	Dasatinib results in decreased expression of TPX2 mRNA	20q11.21	A21899

Displaying entries 29276 - 29300 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability